Background
Methods
Study site
Data collection and Curation
Variable | Visit Count (%) | Odds Ratio (95% CI) | Bivariate p-value |
---|---|---|---|
Date and Time | |||
visit date | 1028 (99.7%) | 0.99 (0.99-0.99) | p < 0.001 ** |
week day | 1028 (99.7%) | range 0.64-1.28 | p = 0.63 |
time of day | 1021 (99.0%) | 0.99 (0.99-0.99) | p = 0.24 |
Patient Characteristics | |||
gender | p = 0.03* | ||
female (reference group) | 636 (61.7%) | - | |
male | 390 (37.8%) | 1.34 (1.02-1.76) | |
not recorded | 5 (0.5%) | - | |
race | p = 0.43 | ||
white (reference group) | 594 (57.6%) | - | |
multiple | 92 (8.9%) | 0.90 (0.55-1.44) | |
Asian | 50 (4.8%) | 0.97 (0.51-1.79) | |
black | 21 (2.0%) | 1.04 (0.38-2.54) | |
Hispanic | 6 (0.6%) | - | |
international | 7 (0.7%) | - | |
Pacific islander | 1 (0.1%) | - | |
not recorded | 260 (25.2%) | - | |
academic status | p = 0.27 | ||
undergraduate student | 932 (90.4%) | - | |
graduate student | 85 (8.2%) | 0.86 (0.52-1.39) | |
spouse/dependent | 3 (0.3%) | - | |
not recorded | 11 (1.1%) | - | |
height (inches) | 1013 (98.2%) | 1.04 (1.00-1.08) | p = 0.02* |
weight (pounds) | 1016 (98.5%) | 1.00 (0.99-1.01) | p = 0.09 |
Visit Characteristics | |||
provider | see Fig 3 | range 0.05–4.63 | p < 0.001** |
days since onset (patient reported) †† | 1016 (98.5%) | 1.02 (1.01-1.03) | p < 0.001** |
severity (patient reported) | p = 0.009* | ||
mild (reference group) | 61 (5.9%) | - | |
moderate | 342 (33.2%) | 0.48 (0.27-0.86) | |
severe | 32 (3.1%) | 1.13 (0.46-2.70) | |
not recorded | 596 (57.8%) | - | |
progression (patient reported) | p < 0.001** | ||
stable/no change (reference group) | 274 (26.6%) | - | |
worsening | 317 (30.7%) | 2.27 (1.77-3.77) | |
improving | 108 (10.5%) | 1.06 (0.60-1.84) | |
not recorded | 332 (32.2%) | - | |
antibiotics in past month | 40 (3.9%) | 0.46 (0.19-1.00) | p = 0.07 |
Additional Diagnosis | |||
upper respiratory infection | 197 (19.1%) | 0.26 (0.16-0.39) | p < 0.001** |
suspicious cough | 77 (7.5%) | 1.02 (0.61-1.67) | p = 0.93 |
allergic rhinitis | 32 (3.1%) | 0.51 (0.19-1.17) | p = 0.14 |
fever | 17 (1.6%) | 2.58 (0.98-6.92) | p = 0.05 |
viral syndrome | 13 (1.3%) | - | - |
tonsillitis | 6 (0.6%) | - | - |
influenza | 4 (0.4%) | - | - |
mononucleosis | 3 (0.3%) | - | - |
Common Symptoms Recorded† | |||
throat symptoms | |||
sore throat | 402 (39.0%) | 1.42 (1.08-1.85) | p = 0.01* |
painful swallowing | 130 (12.6%) | 0.58 (0.37-0.89) | p = 0.02* |
hoarseness | 167 (16.2%) | 0.80 (0.55-1.56) | p = 0.25 |
swollen glands in neck | 112 (10.9%) | 1.08 (0.70-1.63) | p = 0.73 |
systemic symptoms | |||
headache | 244 (23.7%) | 0.79 (0.57-1.09) | p = 0.15 |
documented fever | 68 (6.6%) | 0.70 (0.42-1.17) | p = 0.17 |
fever symptoms (patient reported) | 255 (24.7%) | 0.94 (0.69-1.28) | p = 0.71 |
chills | 147 (14.2%) | 0.94 (0.65-1.37) | p = 0.73 |
sweats | 159 (15.4%) | 1.19 (0.82-1.75) | p = 0.36 |
nasal symptoms | |||
stuffy nose | 665 (64.5%) | 0.86 (0.66-1.14) | p = 0.29 |
sinus congestion | 344 (33.4%) | 0.73 (0.55-0.98) | p = 0.03* |
clear nasal discharge | 215 (20.9%) | 0.71 (0.50-0.99) | p = 0.04* |
purulent nasal discharge | 184 (17.8%) | 0.83 (0.58-1.19) | p = 0.33 |
post-nasal drip sensation | 390 (37.8%) | 0.93 (0.70-1.21) | p = 0.59 |
sinus pain | 79 (7.7%) | 1.69 (1.05-2.69) | p = 0.03* |
sneezing | 101 (9.8%) | 0.39 (0.22-0.66) | p < 0.001** |
pulmonary symptoms | |||
sleep disruption due to cough | 610 (59.2%) | 1.22 (0.93-1.59) | p = 0.15 |
sputum production | 638 (61.9%) | 0.98 (0.75-1.29) | p = 0.91 |
shortness of breath | 348 (33.8%) | 0.74 (0.56-0.97) | p = 0.03* |
chest tightness | 277 (26.8%) | 0.94 (0.69-1.26) | p = 0.67 |
wheezing | 275 (26.7%) | 0.64 (0.48-0.86) | p = 0.003* |
chest pain | 232 (22.5%) | 0.82 (0.60-1.12) | p = 0.22 |
paroxysms of cough | 315 (30.6%) | 0.98 (0.73-1.30) | p = 0.87 |
ear symptoms | |||
ear pain | 48 (4.7%) | 1.02 (0.53-1.88) | p = 0.94 |
ear pressure sensation | 122 (11.8%) | 0.89 (0.58-1.35) | p = 0.60 |
decreased hearing | 34 (3.3%) | 0.81 (0.35-1.69) | p = 0.58 |
GI symptoms | |||
loss of appetite | 129 (12.5%) | 0.82 (0.54-1.23) | p = 0.34 |
abdominal pain | 25 (2.4%) | 0.30 (0.07-0.87) | p = 0.05 |
post-tussive vomiting | 74 (7.2%) | 0.67 (0.41-1.09) | p = 0.10 |
nausea | 63 (6.1%) | 0.46 (0.22-0.86) | p = 0.02* |
vomiting | 48 (4.6%) | 0.44 (0.19-0.89) | p = 0.03* |
diarrhea | 34 (3.3%) | 1.24 (0.59-2.49) | p = 0.56 |
neuro-vascular symptoms | |||
lightheadedness | 47 (4.6%) | 1.29 (0.69-2.35) | p = 0.41 |
Commonly Ordered Labs | |||
chest x-ray | 177 (17.2%) | 2.09 (1.50-2.90) | p < 0.001** |
rapid strep screen | 31 (3.0%) | 0.65 (0.26-1.45) | p = 0.32 |
complete blood count | 85 (8.2%) | 1.40 (0.88-2.21) | p = 0.15 |
Monospot | 27 (2.6%) | 1.83 (0.83-3.95) | p = 0.12 |
influenza A + B | 16 (1.6%) | 0.32 (0.05-1.14) | p = 0.13 |
Common Exam Findings† | |||
ear exam | |||
tympanic membrane (TM) | 27 (2.6%) | 0.08 (0.004-0.40) | p = 0.01* |
bulging | |||
TM retraction | 42 (4.1%) | 0.79 (0.38-1.55) | p = 0.51 |
visible fluid behind TM | 148 (14.3%) | 0.17 (0.09-0.29) | p < 0.001** |
cerumen in canal | 29 (2.8%) | 0.46 (0.15-1.12) | p = 0.12 |
nose exam | |||
mucosal edema | 580 (56.2%) | 0.83 (0.63-1.08) | p = 0.16 |
mucosal erythema | 510 (49.5%) | 0.78 (0.59-1.01) | p = 0.06 |
nasal discharge | 324 (31.4%) | 1.59 (1.20-2.09) | p = 0.001** |
maxillary sinus tenderness | 30 (2.9%) | 1.75 (0.83-3.64) | p = 0.13 |
throat exam | |||
erythema | 209 (20.3%) | 0.79 (0.56-1.10) | p = 0.17 |
lymphoid hyperplasia | 104 (10.1%) | 1.47 (0.96-2.22) | p = 0.07 |
post-nasal drip | 157 (15.2%) | 1.44 (1.00-2.04) | p = 0.04* |
tonsil exam | |||
surgically absent | 42 (4.1%) | 1.13 (0.57-2.14) | p = 0.71 |
erythema | 84 (8.1%) | 0.43 (0.23-0.74) | p = 0.004** |
enlarged | 47 (4.5%) | 1.17 (0.62-2.32) | p = 0.64 |
lymphatics exam | |||
anterior cervical lymphadenopathy, tender | 53 (5.1%) | 1.93 (1.10-3.38) | p = 0.02* |
anterior cervical lymphadenopathy, non-tender | 87 (8.4%) | 0.70 (0.41-1.14) | p = 0.16 |
posterior cervical lymphadenopathy, non-tender | 51 (4.9%) | 0.60 (0.29-1.16) | p = 0.15 |
anterior cervical lymphadenopathy | 99 (9.6%) | 3.05 (2.01-4.66) | p < 0.001** |
posterior cervical lymphadenopathy | 26 (2.5%) | 1.00 (0.41-2.25) | p = 0.10 |
lung exam | |||
wheezing | 215 (20.9%) | 1.92 (1.40-2.61) | p < 0.001** |
rales | 21 (2.0%) | 10.05 (3.69-35.18) | p < 0.001** |
rhonchi | 223 (21.6%) | 2.33 (1.71-3.16) | p < 0.001** |
percussion abnormality | 25 (2.4%) | 9.55 (3.83-28.91) | p < 0.001** |
Statistical methods
Results
Study population and antibiotic prescribing
Factors associated with antibiotic use
Variable | Odds Ratio (95% CI) | p-value |
---|---|---|
Visit and Patient Characteristics | ||
visit date (days) | 0.99 (0.99-0.99) | p < 0.001** |
gender | ||
female (reference group) | ||
male | 1.68 (1.17-2.41) | p = 0.005** |
provider | 0.03-12.3 | p < 0.001** |
onset duration (days) | 1.04 (1.03-1.06) | p < 0.001** |
progression | ||
stable/no change (reference group) | ||
worsening | 1.78 (1.03-3.10) | p = 0.04* |
improving | 0.74 (0.35-1.54) | p = 0.43 |
not recorded | 1.69 (0.87-3.27) | p = 0.12 |
Additional Diagnosis | ||
URI diagnosis | 0.33 (0.18-0.58) | p < 0.001** |
Symptoms | ||
sneezing | 0.39 (0.17-0.86) | p = 0.02* |
vomiting | 0.31 (0.10-0.83) | p = 0.03* |
Exam Findings | ||
lymphatics | ||
anterior cervical lymphadenopathy, tender | 3.85 (1.70-8.83) | p = 0.001** |
anterior cervical lymphadenopathy | 2.63 (1.25-5.54) | p = 0.01* |
lungs | ||
rales | 13.95 (3.31-80.73) | p = 0.001** |
rhonchi | 5.50 (3.08-10.00) | p < 0.001** |
percussion abnormality | 13.02 (4.00-50.09) | p < 0.001** |